Table 1 The relationship between circ5165 and clinical characteristics in 99 CRC patients.

From: circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS

Variable

circ5615

p-value

Low (n = 50)

High (n = 49)

 

Sex

 Male

25

34

0.0494*

 Female

25

15

 

Age

 >60

40

36

0.4417

 ≤60

10

13

 

T stage

 II–III

39

28

0.0265*

 IV

11

21

 

N stage

 0

28

24

0.4843

 I–II

22

25

 

M stage

 0

48

46

0.6297

 I

2

3